Meta Biomed Co. Ltd (059210) — Free Cash Flow Generation Index
Meta Biomed Co. Ltd (059210) has a Free Cash Flow Generation Index of -3.21x as of September 2025. Free cash flow of ₩-3.38 Billion represents -3% of operating cash flow (₩1.05 Billion). See 059210 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Meta Biomed Co. Ltd Free Cash Flow Generation Index (2011–2024)
Historical FCF Generation Index trend for Meta Biomed Co. Ltd across 11 annual periods. Explore 059210 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Meta Biomed Co. Ltd (2011–2024)
Year-by-year Free Cash Flow Generation Index for Meta Biomed Co. Ltd. For the full company profile including market capitalisation, see market cap of Meta Biomed Co. Ltd.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.51x | ₩11.53 Billion | ₩22.63 Billion | ₩11.10 Billion | ▲ +507.7% |
| 2023 | -0.12x | ₩-1.28 Billion | ₩10.22 Billion | ₩11.49 Billion | ▲ +81.7% |
| 2022 | -0.68x | ₩-6.25 Billion | ₩9.16 Billion | ₩15.41 Billion | ▼ -184.0% |
| 2021 | 0.81x | ₩9.04 Billion | ₩11.14 Billion | ₩2.07 Billion | ▲ +154.8% |
| 2020 | 0.32x | ₩1.55 Billion | ₩4.86 Billion | ₩2.23 Billion | ▼ -91.3% |
| 2019 | 3.64x | ₩10.43 Billion | ₩2.86 Billion | ₩7.56 Billion | ▲ +64.1% |
| 2016 | 2.22x | ₩11.16 Billion | ₩5.03 Billion | ₩6.13 Billion | ▼ -14.0% |
| 2015 | 2.58x | ₩12.73 Billion | ₩4.93 Billion | ₩7.79 Billion | ▲ +15.2% |
| 2013 | 2.24x | ₩8.31 Billion | ₩3.71 Billion | ₩4.60 Billion | ▼ -5.6% |
| 2012 | 2.37x | ₩9.09 Billion | ₩3.83 Billion | ₩5.26 Billion | ▼ -21.0% |
| 2011 | 3.00x | ₩12.33 Billion | ₩4.10 Billion | ₩8.22 Billion | — |